The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Published by info, 2022-01-23 23:22:34

E-BOOK CISW SUMMIT 2021

E-BOOK CISW SUMMIT 2021

Keywords: การลงทุน

CANNABIS INVESTMENT SUMMIT WORLD CANNABIS
INVESTMENT
SUMMIT WORLD

ORGANIZE BY
CISW INTERNATIONAL &
CS RECOVERY GROUP

CANNABIS
INVESTMENT

SUMMIT
WORLD

11-13 NOVEMBER 2021

CANNABIS INVESTMENT
SUMMIT WORLD

CISW

CISW is currently one of the biggest event about Cannabis and Hemp in Asia targeting up
to 5,000 attendees from around the world. It’s a 3-day virtual summit for everyone who is
interested in all aspects of the medical cannabis and hemp industry (Research and
Development, Investment opportunities, Science and Therapeutics …).

Cannabis Investment Summit World is the first biggest virtual summit in Asia that brings
together cannabis professionals and stakeholders across industries to share valuable
knowledge and experience. On the eve of cannabis legalization laws, the summit plans to
be a timely and informative conference.

During the 11-13 of November 2020, our dedicated team aims to attract leaders and
investors from both public and private sectors around the world. The CISW is a three-day
event, organized and managed by JBN Global Group and CS Recovery Group (CSG).

The intent of the summit is to bring together
professionals from a wide range of industries
connected to medical cannabis. The goal is to
foster learning, collaboration and innovation.
The virtual conference will provide new
perspectives on this emerging industry, and
how it will impact ASEAN (drive innovation,
create economic advantages…)
As a sponsor, this will be your golden
opportunity to “BE THE LEADER” in Asia’s
cannabis industry and draw attention from both
national and international clients on your
products and services, including research
leaders, educational institutions, investors and
all international cannabis committees.

For more exclusive contents of Jack ong please follow the below link
www.ciswsummit.com

-1-

MORHELLO

CHAIRMAN OF BOARD
THONBURI HEALTHCARE GROUP

"Siriya Thepcharoen" Deputy Chief Marketing
Officer Nusasiri Public Company Limited.
Nusasiri has operated the business and move
towards internationalization. Both in real
estate, tourism and health, etc., and cooperate
with world-class companies in the supervision
and management of various. From a long
history, the company has grown together with
Thai people through all situations.
“We strive to build the Nusasiri brand to take a
big step in a new direction to celebrate our
25th anniversary and moving into the health
business according to the cannabis-hemp
trend.”

The company has also created a new online platform called "Nusatech" to work on
artificial intelligence (AI) technology for research and data collection on health of Thai
people to be an online platform that will be the center of health in one place in the name
of "MORHELLO". A Health and medical platform where consumers can get close to the
doctor through the screen by MORHELLO.

For more exclusive contents of Siriya Thepcharoen please follow the below link
www.ciswsummit.com

-2-

AGENDA

DAY 1

CANNABIS INVESTMENT SUMMIT WORLD

WWW.CISWSUMMIT.COM 2021

-3-

-3-

AGENDA DAY 1
11th NOVEMBER 2021

Dr. Jintana Manorompatrasal

“Sharing Clinical expertise in Thailand's medical
cannabis treatment (10,000 cases)”

Assoc.Prof.Dr. ThavatchaiKamoltham

“Information on vision and strategy as a
young national guru about cannabis”

Dr. Mark Braunstein

"Cannabinoid Assisted Psychotherapy for
Mental Health Disorders"

Dr. Uma Dhanabalan

"The past, the present, and the future"

-4-

AGENDA DAY 1
11th NOVEMBER 2021

Dr. Andrew Agius

"The use of minor cannabinoids in the
management of chronic pain"

Dr. Vasko Dinev

"Evidence-based medicine, GCP, GMP, etc."

Dr. Sandra Carrillo

“Medical Cannabis Scientific
Evidence, Clinicians Perspective”

Prof.Dr. Anuvat Roongpisuthipong

“Cannabis as a potential treatment for
COVID-19”

-5-

AGENDA

DAY 2

CANNABIS INVESTMENT SUMMIT WORLD

WWW.CISWSUMMIT.COM 2021

-6-

AGENDA DAY 2
12th NOVEMBER 2021

Glen Kayll

“Hemp Plastics - the next
biggest thing in cannabis hemp
industry”

Jimmy Sadegi

“BACK TO THE FUTURE with
Cannabis Genetics”

Srinivasa Reddy

“The Therapeutic Potential of
Cannabinoids on Health System”

Tracy Ryan

“Saving Sophie: One Mom's
Journey to Find a Cure Using
Cannabis and Cell Therapy”

-7-

AGENDA DAY 2
12th NOVEMBER 2021

Morris Johnson

“Broad Industry-wide paradigm
shift progress during 2021 and
benchmarks, milestones and
goals for 2022”

Ramon Granados

“Project Management Process for
Large Scale Hemp Projects”

Johan Mohamad

“Paving the way for Industrial Cannabis
- An Exemplary paradigm on iHemp &
UNSDGs 2030 "

Wilson Chai

“HEMP City -Paradise in the Making”

-8-

AGENDA DAY 2
12th NOVEMBER 2021

Yosi Sherman

“Medicinal Cannabis Security
and Regulation”

Nick Tulloch

“The Outlook for the CBD Market”

Sergiy Kovalenkov

“Innovative use of hemp in
sustainable construction
industry”

Adam Shuster

“Agro systems of growth
A.outdoor B.Greenhouse.
C.Indoor”

-9-

AGENDA

DAY 3

CANNABIS INVESTMENT SUMMIT WORLD

WWW.CISWSUMMIT.COM 2021

- 10 -

-3-

AGENDA DAY 3
13th NOVEMBER 2021

Dale Sky Jones

“International trade, laws and
regulations, and the global
investment market”

Marcus Ramkissoon

“International Cannabis – A
Regulatory and Business Update”

Stephen Oliver

“A Regulatory overview of the
EU and UK for both the CBD
market and Medicinal
Cannabis”

Dr. Thomas E. Fernandez

“Customs Regulations for
Cannabis and Cannabis Products”

Michael Patterson

“Investing in International
Medical Cannabis and Hemp
Companies”

- 11 -

AGENDA DAY 3
13th NOVEMBER 2021

Robert W.E. Laurie

“Psychedelic Decriminalization And Its
Impact on Policy Reform”

Felix Mago

“Tokenize everything – how to build secondary
markets in the cannabis industry”

Albert Tió

“A new strategy for cannabis law
reform in Spain, Europe and the
world: Green Light”

“"

Farid Ghehioueche

“Cannabis, as the tool to achieve SDG before 2030”

- 12 -

CISW
SPEAK

CANNABIS
SUMM

- 13 -

ORGANIZE BY CISW INTERNATIONAL & CS RECOVERY GROUP




TOP
KERS

INVESTMENT
T WORLD

- 14 -

TOPIC

ORGANIZE BY CISW INTERNATIONAL & CS RECOVERY GROUP

1st DAY

“MORHELLO DAY”
MEDICAL DOCTOR RESEARCH & DEVELOPMENT

2nd DAY

LAWS & REGULATIONS
GLOBAL INVESTMENT MARKET

3rd DAY

MEDICAL CANNABIS
TOURISM & WELLNESS GLOBAL DEVELOPMENT

- 15 -

1st DAY

11th NOVEMBER 2021

“MORHELLO DAY”
MEDICAL DOCTOR

RESEARCH &
DEVELOPMENT

ORGANIZE BY CISW INTERNATIONAL &
CS RECOVERY GROUP




- 16 -

11TH NOVEMBER 2021 TOPIC

“SHARING CLINICAL
EXPERTISE IN THAILAND'S
MEDICAL CANNABIS
TREATMENT (10,000
CASES)”

For over 30 years, Dr. Jintana focuses her
specialization in rehabilitation medicine and cancer
care. She found the wonder of Cannabis as she
searched for solutions to aid her cancer patient's
pain. It marked as the most rewarding time in her
professional years and has been treating her
patients at Sawasdee Clinic ever since.

Today she will tell the story of over 10,000 patients
from final-stage Cancer, Parkinson's disease,
Alzheimer's, Depression, Autism, Multiple Sclerosis,
Chronic Pain, and many more. With a combination
of conventional cannabis and hundreds of Thai
herbal pharmacopeias, the treatment potential
goes far beyond anywhere in the world.

DR. JINTANA MANOROMPATRASAL

MD, PSYCHIATRIST, MEDICAL CANNABIS
SPECIALIST

- 17 -

ASSOC.PROF.DR. THAVATCHAI KAMOLTHAM

DEAN OF COLLEGE OF ALLIED HEALTH
SCIENCES,
SUAN SUNANDHA RAJABHAT UNIVERSITY

11TH NOVEMBER 2021

TOPIC

“INFORMATION ON VISION
AND STRATEGY AS A YOUNG
NATIONAL GURU ABOUT
CANNABIS”

Sharing information on vision and strategy as a
young national guru about cannabis. Our mission is
to build people with real knowledge of cannabis.

We do research, build a laboratory, factory, and
medical clinic about cannabis in the same place. And
how to collaborate in the cannabis business.

- 18 -

11TH NOVEMBER 2021 TOPIC
DR. MARK BRAUNSTEIN
PSYCHIATRIST, CEO &
FOUNDER, RECONSCIOUS
MEDICAL

Cannabis has continued to evolve alongside
humans for centuries, therefore cannabis today is
very different from that of the ’60s. It is more potent,
as well as more therapeutic. Advances in cultivation
technology and an increasing amount of data on
cannabis effects, have set the stage for a new
frontier of customized plant medicine.
One such frontier is Cannabinoid Assisted
Psychotherapy.
Unfortunately, nearly 90% of residents and fellows
report that they do not feel prepared to prescribe
medical cannabis to patients. Providing guidance to
these medical providers, so they feel more
comfortable diagnosing mental health disorders,
understanding the endocannabinoid system in
relation to mental health disorders, and
implementing Cannabinoid Assisted Therapy as a
treatment for mental health disorders can help
change the world.
You have the Power to Change the World.

MEDICAL DOCTOR AT RECONCIOUS MEDICAL

- 19 -

DR. UMA DHANABALAN

MD MPH FAAFP MRO CMS - U.S.A.

11TH NOVEMBER 2021

TOPIC

“THE PAST, THE PRESENT,
AND THE FUTURE”

Dr. Uma Dhanabalan is a highly respected and educated
physician and known to most as Dr. Uma. She completed her
Bachelor of Arts degree with high honors from Rutgers
University and Medical Degree from the University of Medicine
& Dentistry in Newark, New Jersey. She completed her Family
Practice Residency at the Medical University of South Carolina,
in Charleston, South Carolina. She has her Master’s in Public
Health and completed her Occupational & Environmental
Medicine Residency and Fellowship in heavy metals at the
Harvard School of Public Health in Boston Massachusetts. She
a Fellow, of the American Academy of Family Physicians. She is
also Certified by the American Academy of Cannabinoid
Medicine as a Cannabinoid Medicine Specialist and by the
Medical Review Officer Certification Council as a Medical
Review Officer.

Her mission is to change the Stigma regarding Cannabis and
for the world to know about the Endocannabinoid system
through educationDr Uma Says®, “Cannabis is not for
everyone, yet it should be a first line option not the last resort”
and “Cannabis is not an entrance drug, it is an exit drug from
pharmaceuticals, narcotics, alcohol and nicotine.” “Cannabis
The Exit Drug®”

- 20 -

11TH NOVEMBER 2021 TOPIC

“THE USE OF MINOR
CANNABINOIDS IN THE
MANAGEMENT OF CHRONIC
PAIN”

Chronic pain is a worsening global
pandemic affecting at least 20% of the adult
population. Pharmaceutical options are
limited and may cause unwanted side
effects. Medical cannabis with THC can
reduce pain levels by at least 50% but may
cause side effects in high doses.

CBD, CBG, and CBN are minor
cannabinoids that can enhance the pain-
relieving effect of THC while reducing side
effects. By combining THC with other
cannabinoids, we can achieve optimal pain
relief with little or no side effects. Stay tuned
to find out how the best medicines for pain
are formulated.

DR. ANDREW AGIUS

MD MSC EDPM | MEDICAL DIRECTOR

- 21 -

DR. VASKO DINEV

CO-FOUNDER OF IMPERIAL GREEN LTD., NORTH
MACEDONIA

11TH NOVEMBER 2021

TOPIC

“EVIDENCE BASED MEDICINE,
GCP, GMP, ETC…”

Dr. Vasko Dinev has obtained his diploma in Human Medicine in
2006 and started his career in clinical research, in organizing and
conducting clinical trials. In more than 10 years of working in
clinical research, as senior officer on different global cross-
functional positions, he was involved in substantial number of
clinical trials (pediatrics, vaccines, Phase I-IV) with various medical
indications. Dr. Dinev is also a co-author of GCP Patient Brochure,
approved and endorsed by various regional regulators, intended
to increase the awareness of the patients for the possibilities and
opportunities in participation in clinical trials.

In 2017, he co-founded “Imperial Green Ltd.”, a consultancy
company with focus on medical cannabis. Imperial Green as
company is specialized into local regulations, project management,
business development and implementation of industry standards.
Also, through his company, Dr. Dinev is partner in one of the
biggest medical cannabis cultivation facilities in Republic of North
Macedonia, where he is involved as Advisor of the Executive Board.

- 22 -

11TH NOVEMBER 2021 TOPIC

“MEDICAL CANNABIS
SCIENTIFIC EVIDENCE,
CLINICIANS PERSPECTIVE”

Speaking about the Scientific Evidence
regarding the use of Cannabinoids
Based Medicine in the treatment of
different pathologies. Discussing
different Levels of Evidence, focusing
on the most relevant RCT, Systematic
Reviews, published to date and the
applications for physicians in their
clinical practice.

DR. SANDRA CARRILLO

MEDICAL DOCTOR, PROFESSOR, CO-FOUNDER
OF MEDICANN IPS MEDICAL CANNABIS CLINICS
(COLOMBIA)

- 23 -

PROF.DR. ANUVAT ROONGPISUTHIPONG

CHIEF OF CANNABIS HEALTH SCIENCE,
DIRECTOR OF ALLIED HEALTH SCIENCE
RESEARCH CENTER

11TH NOVEMBER 2021

TOPIC

“CANNABIS AS A POTENTIAL
TREATMENT FOR COVID-19”

As we all know that Covid-19 is a serious contagious and
widespread viral infection all over the world, resulting in millions of
dead cases from a severe pulmonary infection. The scientists are
also looking for preventive and treatment measures for covid 19
infection.

Cannabis could be used as a potential treatment of this infection.
The main target is to reduce inflammation in the patient's lungs
which will result in lung fibrosis and make it difficult to breathe and
die. The process of inflammation called cytokine storm concerning
2 cytokines. IL6+TNFa as an important target for treatment.

THC and CBD are useful in the treatment of covid 19. Some
scientists found that specific terpine in Cannabis can also help to
treat covid 19. Some scientists in many research institutes are
working hard to prepare and report the study of cannabis as a
treatment of covid 19 which will come out as a peer-reviewed
scientific paper soon.

- 24 -

TOPIC

ORGANIZE BY CISW INTERNATIONAL & CS RECOVERY GROUP

1st DAY

“MORHELLO DAY”
MEDICAL DOCTOR RESEARCH & DEVELOPMENT

2nd DAY

LAWS & REGULATIONS
GLOBAL INVESTMENT MARKET

3rd DAY

MEDICAL CANNABIS
TOURISM & WELLNESS GLOBAL DEVELOPMENT

- 25 -

2nd DAY

12th NOVEMBER 2021

MEDICAL
CANNABIS
TOURISM &
WELLNESS GLOBAL
DEVELOPMENT

ORGANIZE BY CISW INTERNATIONAL &
CS RECOVERY GROUP




- 26 -

12TH NOVEMBER 2021 TOPIC

GLEN KAYLL “HEMP PLASTICS - THE
NEXT BIGGEST THING IN
CEO OF THE HEMP PLASTIC COMPANY CANNABIS HEMP
INDUSTRY”

Hemp deregulation and industrial hemp
expansion have come at an important time
in world history. We, as caretakers of this
planet, are being forced to tackle the
massive dual challenges of global plastics
pollution and carbon emissions. Hemp
plastics represent a meaningful, innovative,
cost-effective, and near-term approach to
these challenges.

Plastic converters and consumers are taking
note and taking action. Hemp plastic is
contributing to the sustainability initiatives
of dozens of leading Tier 1 and medium-
sized organizations alike, as consumers,
governments, and investors demand
action. Mr. Kayll’s presentation will discuss
the growth of industrial hemp, its
implications beyond CBD and
nutraceuticals, and the hemp plastic
solutions that are available today.

- 27 -

JIMMY SADEGI

CO-FOUNDER & CHIEF GENETICS OFFICER
THE ORIGINAL BREEDERS LEAGUE

12TH NOVEMBER 2021

TOPIC

“BACK TO THE FUTURE WITH
CANNABIS GENETICS”

Breeding is the last frontier the industry will explore. Although
breeding and genetics are the last frontier, this segment of the
cannabis industry will prove to be the most significant to the
advancement and sustainability of the cannabis sector as a
new multi-billion dollar global industry.

Understanding the history of Breeding cannabis genetics, what
the current problems are in the world of breeding and
cannabis genetics and finally highlighting the current & future
opportunities working in breeding and cannabis genetics will
give audience members a clearer understanding of how
tantamount genetics are to the success of the industry, the
profound impact cannabis genetics have on businesses and
finally how significant breeding is for cannabis’s effectiveness
on patients and customers.

It all starts with a seed.

- 28 -

12TH NOVEMBER 2021 TOPIC

SRINIVASA REDDY “THE THERAPEUTIC
POTENTIAL OF
FOUNDER AND COO OF CUBE PSYTECH CORP. CANNABINOIDS ON
HEALTH SYSTEM”

The recent trend for legalization of medicinal
cannabis and cannabinoid-containing products,
together with their soporific effects, has led to a
surge of interest of their potential therapeutic
role in the management of some common
sleep disorders, such as insomnia, sleep
disordered breathing, and restless legs
syndrome, and less common disorders such as
narcolepsy and parasomnias, chronic pain
management, epilepsy etc,.

Although much of the pre-clinical and clinical
data were derived from studies with relatively
small sample sizes and limited by biases in
assessment, and in clinical trials lack of
allocation concealment, as a whole, there is a
potential therapeutic role for cannabinoids in
the management of several health issues.
Clinical trials are underway for several health
disorders, but there remains a substantial need
for rigorous large multi-center studies to assess
the dose, efficacy, and safety of the various
types of cannabinoids on specific targeted
issues.

- 29 -

TRACY RYAN

CO-FOUNDER & CHIEF MARKETING OFFICER OF
NKORE BIOTHERAPEUTICS

12TH NOVEMBER 2021

TOPIC

“SAVING SOPHIE: ONE MOM'S
JOURNEY TO FIND A CURE
USING CANNABIS AND CELL
THERAPY”

After Tracy Ryan’s daughter’s brain tumor diagnosis
at 8 ½ months old, she quickly learned of the few
advancements in pediatric cancer treatments over
the last 40 years. When the Ryan's became a
featured family in the Ricki Lake-produced Netflix
documentary, Weed the People, they set off on a
course to understand both cannabis as a medicine,
and how it worked with Natural Killer Cells as a
possible cancer therapy and preventative. Now
almost 9 years later, Tracy has launched her own
immunotherapy company and has set a course
towards human trials as she gets one step closer to a
cure for Sophie.

- 30 -

12TH NOVEMBER 2021 TOPIC

MORRIS JOHNSON “BROAD INDUSTRY-WIDE
PARADIGM SHIFT
CEO/CTO OF LIFESPAN RESEARCH INC. PROGRESS DURING 2021
AND BENCHMARKS,
MILESTONES AND GOALS
FOR 2022”

Paradoxically 2021 North American hemp indoor
and outdoor acreage plummeted just as emerging
research suggests CBD and the cannabis bioactive
entourage may be a key part of the complementary
toolbox to treat and prevent Covid and also
constitute an anti-aging mainstream food
supplement.

Economic models of DIY, craft, corporate, and agri-
food are converging into an integrated distributed
global model.

Regulatory goals include an MDR and RDA for CBD
and other cannabis bioactive.Billions in investment
capital pouring into the emerging anti-aging meta
industry constitute the pull the cannabis and hemp
industry needs to create long-term sustainable
growth as 7.8 billion customers have unmet needs
we can fill.

- 31 -

RAMON GRANADOS

FOUNDER & CEO HEMP ENGINEERING PTY LTD

12TH NOVEMBER 2021

TOPIC

“PROJECT MANAGEMENT
PROCESS FOR LARGE SCALE
HEMP PROJECTS”

Since the dawn of Green Rush, $ Billions have been
pumped into the Cannabis Industry to build up the
infrastructure to operate a Supply Chain Operation
that in many cases, the project has been
unsuccessfully delivered for lack of EPCM good
practices of Planning & Project Controls.
With the expansion of the Industry into Biomass
Engineered products, this specialized Project
Management service became very useful and
supportive in the O&G Industry expansion in the last
35 years to monitor Project deliveries and operations
in multiple countries and continents.

- 32 -

12TH NOVEMBER 2021 TOPIC

JOHAN MOHAMAD PAVING THE WAY FOR
INDUSTRIAL CANNABIS
FOUNDER AND PRESIDENT OF MHIRA - AN EXEMPLARY
PARADIGM ON IHEMP &
UNSDGS 2030”

Sustainability and hemp policies can be perfect tools and
resources for our government to achieve the UN
Sustainable Development Goal Global Indicator and we
have identified that hemp policies can provide great
potential for the government to achieve 64 out of 231
Goal Global Indicators. This is an important policy toolkit
adopted by global consensus in 2016. We will be focusing
on 4 out of 7 thematic chapters outlined in UNGASS 2016
which is human rights, new trends, international
cooperation, and development.

MHIRA (Malaysia Hemptech Industrial Research
Association) would like to provide relevant information to
show the potential of the hemp plant, with an
appropriately regulated setting, has a great potential to
create a transformative impact for our society and our
nation, so long as ethical practice and sustainable
approaches are kept central by providing an in-depth
understanding of how industrial hemp can be linked with
sustainable development goals.

- 33 -

WILSON CHAI

CMO OF HEMP SMART CITY

12TH NOVEMBER 2021

TOPIC

“HEMP CITY -PARADISE IN
THE MAKING”

HEMP City -Paradise in the Making, explores the
making of the future city for people from all walks of
life to enjoy, and is ready to occupy family or holiday
or retirement homes with resort quality facilities and
amenities.

Our resort offers several exceptional wellness
facilities you won't find anywhere else, including
state-of-the-art hemp spa.
Best Wellness Retreats to Restore Your Mind, Body,
and Soul tailored to your body needs and
requirements. This is a World Mega Project created
to take the world by storm...

- 34 -

12TH NOVEMBER 2021 TOPIC

“MEDICINAL CANNABIS
SECURITY AND
REGULATION”

Why do we need to talk about the
security of medical cannabis?
Threat severity - graph with the
high alert threat, High Monetary
Value, Hot - coveted product,
Multiple uses, Privacy.

The need for a GAP-FREE “seed-to-
sale” secure supply chain. 360°
GAP-FREE SECURITY SOLUTION,
Physical security, Intelligence,
Information security.

YOSI SHERMAN

INTERNATIONAL SECURITY EXPERT,
CEO OF PHARMA SECURITY

- 35 -

NICK TULLOCH

FOUNDER AND CEO, VOYAGER LIFE

12TH NOVEMBER 2021

TOPIC

“THE OUTLOOK FOR THE CBD
MARKET”

The use of CBD is growing rapidly
worldwide and several factors,
particularly regulation and
consumer attitudes, look set to
define the next stage in this
exciting market.

- 36 -

12TH NOVEMBER 2021 TOPIC

“INNOVATIVE USE OF
HEMP IN SUSTAINABLE
CONSTRUCTION INDUSTRY”

As the population of the world grows bigger
day by day the question of habitat (housing)
raising concerns among politicians, scientists,
construction industry leaders. The construction
sector is the biggest carbon emitter on the
planet. The amount of minerals on the planet is
finite, and therefore infinite economic growth
(in the construction sector as well) can only
continue through regenerative agriculture.

Hemp is a magical agricultural crop that can
provide enough biomass to manufacture
carbon-negative construction materials and
fulfill market demand. In fact, it’s being done
right now.

SERGIY KOVALENKOV

CEO AT HEMPIRE

- 37 -

ADAM SHUSTER

CO-FOUNDER OF BH SYNERGY GROUP INC.

12TH NOVEMBER 2021

TOPIC

“AGRO SYSTEMS OF GROWTH
A.OUTDOOR B.GREENHOUSE.
C.INDOOR”

Agro systems of growth A. Outdoor B.
Greenhouse C. Indoor, Soil medium,
and orpen field nutrients, by a 30 year
experienced Agronomist, Special
airflow systems bio bacteria to protect
your indoor and greenhouse grow,
increase of yield of cannabis by 20%!
Patented system.

- 36 -

TOPIC

ORGANIZE BY CISW INTERNATIONAL & CS RECOVERY GROUP

1st DAY

“MORHELLO DAY”
MEDICAL DOCTOR RESEARCH & DEVELOPMENT

2nd DAY

LAWS & REGULATIONS
GLOBAL INVESTMENT MARKET

3rd DAY

MEDICAL CANNABIS
TOURISM & WELLNESS GLOBAL DEVELOPMENT

- 37 -

3rd DAY

13th NOVEMBER 2021

LAWS &
REGULATIONS

GLOBAL
INVESTMENT

MARKET

ORGANIZE BY CISW INTERNATIONAL &
CS RECOVERY GROUP




- 38 -

13TH NOVEMBER 2021 TOPIC

“INTERNATIONAL TRADE,
LAWS AND REGULATIONS,
AND THE GLOBAL
INVESTMENT MARKET”

To participate and compete in the global cannabis
marketplace, thoughtful regulation is key. The laws
in each country determine the viability of successful
production, manufacturing for export, and
attracting investments for the required
infrastructure. Regulations must ensure that
product adheres to European good agricultural and
manufacturing practices (GAP), the strictest in the
world and where the wealthy consumer import
markets currently exist.

Importantly, permit types and access to licenses,
along with quality education, can determine the
course for local job creation and equity. Focus on
health, safety, and wealth-building for the nation,
citizens, and environmental management in law.

DALE SKY JONES

EXECUTIVE CHANCELLOR AT OAKSTERDAM
UNIVERSITY

- 39 -

MARCUS RAMKISSOON

CANNABIS POLICY SPECIALIST & DIRECTOR OF
CARIBBEAN CANNABIS INSTITUTE

13TH NOVEMBER 2021

TOPIC

“INTERNATIONAL CANNABIS –
A REGULATORY AND
BUSINESS UPDATE”

Licensed Cannabis business operations are now
regulated in many parts of the world. Cannabis
regulations are not yet uniform and many variances exist
within the existing frameworks. This presentation will
briefly examine the newest regulatory updates within the
industry and highlight particular regulatory clauses and
their implications.
Like most manufacturing and processing industries,
Cannabis businesses can operate on a national, regional,
and international level. Mr. Ramkissoon will focus on
realistic business models, products, and available
markets within the international Cannabis industry and
will seek to update investors and entrepreneurs
regarding the international market changes and business
feasibility in various regions and countries.

- 40 -

13TH NOVEMBER 2021 TOPIC

“A REGULATORY
OVERVIEW OF THE EU AND
UK FOR BOTH THE CBD
MARKET AND MEDICINAL
CANNABIS”

Confusion reigns in the UK and across Europe from
the lack of policy, communication, and harmony in
the approach to Novel foods.Which factors are
preventing the industry from moving forwards with
certainty, how can businesses protect themselves
whilst planning for the future and what will that
future look like?

It is now the three-year anniversary of the change in
UK law which promised greater access to Cannabis-
Based Products for Medicinal Purposes (CBPM’s).
With only four patients receiving medication on the
National Health Service; what has happened, what
will happen, and what has to happen to resolve
this?

STEPHEN OLIVER

CO-FOUNDER OF THE CANNA CONSULTANTS

- 41 -

DR. THOMAS E. FERNANDEZ

SUPPLY CHAIN CONSULTANT, LECTURER AND
RESEARCHER, UNIVERSITY OF THE THAI
CHAMBER OF COMMERCE

13TH NOVEMBER 2021

TOPIC

“CUSTOMS REGULATIONS FOR
CANNABIS AND CANNABIS
PRODUCTS”

Medical Cannabis is being legalized in more and
more countries. Apart from domestic
consumption, the export and import of cannabis
products are increasing. However, since this is still
a fairly new commodity in (legal) international
trade, each country is updating their laws and
regulations. Even within the EU, the regulations
differ from country to country, and in the US, they
even differ from state to state.
This presentation is taking a snapshot of the
current situation about import and export
requirements in several countries in the world.
This update on the situation also takes a look at
the future.

- 42 -

13TH NOVEMBER 2021 TOPIC

“INVESTING IN
INTERNATIONAL MEDICAL
CANNABIS AND HEMP
COMPANIES”

Learn about current and future
trends in medical cannabis, hemp,
and adult-use cannabis markets
globally. Discover the opportunities
and challenges associated with an
investment in these markets. We
will discuss specifics on proper
licensure, questions to ask prior to
investment, and expected return
on investment capital.

MICHAEL PATTERSON

CEO OF US CANNABIS PHARMACEUTICAL
RESEARCH AND DEVELOPMENT LLC

- 43 -

ROBERT W.E. LAURIE

AN INTERNATIONAL LAWYER, PRESIDENT OF AD
LUCEM LAW CORPORATION

13TH NOVEMBER 2021

TOPIC

“PSYCHEDELIC
DECRIMINALIZATION AND ITS
IMPACT ON POLICY REFORM”

Robert W.E. Laurie of AD LUCEM LAW CORPORATION
will discuss the prohibition and scheduling of
psychedelics by international convention and the
unfortunate consequences of the American-led war
on drugs on research and science. Robert will explain
the state of Canada’s laws and regulations
surrounding psychedelics, providing a comparative
analysis of the trends and lessons learned from the
near twenty-year litany of medical cannabis access
jurisprudence involving Section 7 of the Canadian
Charter of Rights and Freedoms. Building upon the
cannabis jurisprudence, Robert will explore medical
access trends involving psychedelic decriminalization
and its impact on policy reform.

- 44 -

TOPIC

“TOKENIZE EVERYTHING –
HOW TO BUILD
SECONDARY MARKETS IN
THE CANNABIS INDUSTRY”

13TH NOVEMBER 2021 Crypto has enabled the easy and
decentralized creation of primary and
secondary markets. But these markets
are not limited to crypto-assets—quite
the contrary. Everyone can now design
their economics and release their own
assets. Imagine, for example, releasing a
token for your next harvest.

FELIX MAGO

CO-FOUNDER OF DASH NEXT

- 45 -


Click to View FlipBook Version